Medicus Pharma COO granted 200,000 stock options
Medicus Pharma Ltd. Chief Operating Officer Andrew Alasdair Smith received a grant of stock options covering 200,000 common shares on June 3, 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Medicus Pharma Ltd. Chief Operating Officer Andrew Alasdair Smith received a grant of stock options covering 200,000 common shares on June 3, 2026. The options have an exercise price of $0.36 per share, vest quarterly in four equal installments over one year, and expire on June 3, 2031. Following this grant, he holds 200,000 options directly.
Insider Trade Summary
Grant/Award: 200,000 shares
Grant/Award
1 txn
Insider
Smith Andrew Alasdair
Role
Chief Operating Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (right to buy) | 200,000 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (right to buy) — 200,000 contracts (Direct)
Footnotes (1)
- F1. The option was granted on June 3, 2026. The option is scheduled to vest quarterly in four equal installments over one year.
Key Figures
Option grant size: 200,000 options
Exercise price: $0.36 per share
Underlying shares: 200,000 common shares
+3 more
6 metrics
Option grant size
200,000 options
Stock Option (right to buy) granted June 3, 2026
Exercise price
$0.36 per share
Conversion or exercise price for the options
Underlying shares
200,000 common shares
Underlying security shares for the option grant
Total options after grant
200,000 options
Total shares following transaction, held directly
Expiration date
June 3, 2031
Option expiration date
Vesting schedule
Quarterly over one year
Four equal installments per footnote
Key Terms
Stock Option (right to buy), exercise price, expiration date, vesting, +1 more
5 terms
Stock Option (right to buy) financial
"security_title: Stock Option (right to buy)"
exercise price financial
"conversion_or_exercise_price: 0.3600"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
expiration date financial
"expiration_date: 2031-06-03T00:00:00.000Z"
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
vesting financial
"The option is scheduled to vest quarterly in four equal installments"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
grant, award, or other acquisition financial
"transaction_code_description: Grant, award, or other acquisition"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Medicus Pharma (MDCX) COO Andrew Smith report on this Form 4?
He reported receiving a grant of 200,000 stock options. These options give him the right to buy Medicus Pharma common shares at a fixed exercise price, reflecting equity-based compensation rather than an open-market stock purchase or sale.
How many stock options did Medicus Pharma (MDCX) grant to its COO?
Medicus Pharma granted 200,000 stock options to its Chief Operating Officer. Each option is linked to one common share, providing potential future ownership if exercised once vesting conditions are met during the specified schedule and before expiration.
What is the exercise price of the Medicus Pharma (MDCX) options granted?
The stock options have an exercise price of $0.36 per share. This price is the fixed amount the COO must pay per share to convert options into common shares once they are vested and exercised before expiration.
When do the Medicus Pharma (MDCX) COO’s stock options vest?
The options are scheduled to vest quarterly in four equal installments over one year. This means 25% of the 200,000 options vest every quarter, aligning the grant with ongoing service over the one-year vesting period.
When do the newly granted Medicus Pharma (MDCX) stock options expire?
The options expire on June 3, 2031. After this expiration date, any unexercised options become worthless, so the COO must exercise vested options before that date to acquire the underlying common shares.
How many Medicus Pharma (MDCX) options does the COO hold after this grant?
Following this transaction, the COO is shown as holding 200,000 stock options directly. This figure represents his derivative position reported in the filing after receiving the new grant, all tied to Medicus Pharma common shares.
AI-generated analysis. How Rhea-AI works. Not financial advice.
